World Drug Sales Up 4% In First Seven Months

9 October 1994

Worldwide, prescription drug purchases made at retail pharamacies during January-July 1994 rose 4% compared to the same seven-month period of 1993 to a level of $68.2 billion, according to figures published last week by IMS International.

North American sales increased by 7% during the period to reach $29.8 billion, with sales in the USA growing 7% to $27.9 billion and Canadian retail turnover advancing 2% to $1.9 billion. Europe's top seven markets grew 2% overall to $26.1 billion during the period, although the individual markets' experiences were very varied, as cost containment measures continued to take effect.

For example, sales in Germany rose 5% to $7.5 billion, while in France they advanced only 1% to just over $7 billion, and in Italy, where cost-saving measures were introduced at the start of the year, business showed a sharp 7% decline to $4.3 billion from just under $5 billion in the first seven months of 1992. Turnover in the UK, on the other hand, showed an increase of 8% to $3.1 billion, while Spain saw business rise 3% to $2.2 billion, purchases in the Netherlands increased 5% to $968 million and sales in Belgium were up 3% to $908 million.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight